This article summarizes the clinical studies published during 2010 to 2013 on Fuzheng Huayu capsule/tablet. Fuzheng Huayu capsule/tablet shows definite curative effects in treating liver fibrosis， liver cirrhosis and its complications. Several clinical studies have confirmed that Fuzheng Huayu capsule/tablet can treat liver fibrosis and cirrhosis caused by hepatitis B virus and other chronic liver diseases， can improve the curative effects by combining with nucleoside/nucleotide analogues， interferon/pegylated interferon， ursodesoxycholic acid or other drugs. In addition， studies of using human samples to reveal the mechanisms of Fuzheng Huayu capsule/tablet were carried out too. The future studies of Fuzheng Huayu capsule/tablet may have the following trends： 1) to expand indication; 2)to improve the curative effects by combining with more other drugs; 3) to optimize the formula; 4) to develop new dosage forms; 5) to further reveal the mechanisms of Fuzheng Huayu capsule/tablet.